A vaccine tycoon has bet on Bollywood. Will his wager pay off?

Valuing Dharma at ₹2,000 crore, the deal underscores the growing influence of external investments in entertainment while highlighting the urgent need for fiscal discipline within the industry. For a sector long criticized for financial mismanagement, this investment offers both a fresh start and a much-needed wake-up call.

What makes Poonawalla’s move particularly noteworthy is that he comes from outside the Bollywood ecosystem. This isn’t another insider expanding their portfolio; it’s serious capital from a business leader with no prior experience in film production.

As the head of the Serum Institute of India, Poonawalla brings a fresh perspective the industry sorely needs. His involvement also signals that influential voices beyond Bollywood’s inner circle are beginning to recognize the untapped growth potential in Indian cinema.

Also read: Bachchans, Janhvi lead Bollywood's real estate deals in Mumbai

The capital infusion is expected to fuel large-scale productions, multilingual films, and franchise-building efforts, enabling Dharma to broaden its footprint. Both Dharma and Serene Productions are aligned with the evolving content landscape, where digital platforms are taking center stage. This partnership positions them to develop ambitious projects with the potential to compete on a global scale.

Box-office blues

The Hindi film industry is grappling with challenges that are stifling its growth. Declining box-office numbers stem largely from insufficient investment in story development and writing.

The current business model remains skewed toward exorbitant star fees, often at the expense of content quality. This imbalance has resulted in uninspiring films that fail to engage audiences, further eroding the industry’s appeal.

Financial inefficiencies, frequent budget overruns, and a lack of accountability are widespread. Projects are often greenlit without thorough risk assessments, deepening the sector's financial troubles.

At the same time, the rise of streaming platforms is reshaping the entertainment landscape, pulling audiences away from traditional studios like Dharma. Much like Hollywood, where streaming services have disrupted conventional studios, India is experiencing a similar shift. Platforms such as Netflix, Amazon Prime, and Disney+ Hotstar are gaining ground.

Also read: India can set precedent on fair-share levy on OTT platforms: GSMA's Gorman

In this context, Poonawalla’s investment in Dharma is a strategic move to fortify the studio's position against OTT dominance. The capital infusion could enable Dharma to produce high-quality films that appeal to both cinema-goers and digital audiences, bridging the divide between theatres and streaming platforms.

Bollywood’s financial makeover

Poonawalla’s involvement offers hope that the era of reckless spending and lax accountability may be coming to an end. External investors will demand greater financial discipline and clearer returns on investment. For Dharma and the broader industry, the message is clear: to attract serious capital, film production must adhere to the same rigor, transparency, and accountability expected of any large-scale enterprise.

This deal could mark the beginning of a new chapter for Indian cinema—one where fiscal responsibility aligns with creative ambition. It signals to the industry that meaningful investment will flow only to companies that demonstrate growth potential, innovation, and financial stability.

Also Read: Mint Explainer: Why telcos seek fair share on top of bundled OTT plans

As other production houses observe this partnership, a broader shift in practices is likely. Investors will push for tighter scrutiny over how films are budgeted, produced, and marketed. Producers will need to move beyond chasing short-term box office returns, focusing instead on sustainable content strategies and long-term brand development.